Company
NIMBLE Diagnostics
- Biotech
- Location:
- Barcelona (Badalona, Spain)
Description
NIMBLE Diagnostics develops a microwave-based, non-invasive point-of-care system to monitor implanted cardiovascular stents and detect malfunction such as blockages or fractures for clinicians and patients.
Related
Esperion Therapeutics ($ESPR)Esperion Therapeutics develops and commercializes oral cardiovascular therapies that lower cholesterol and related risk factors, and…
POWERFUL MEDICAL s.r.o.Builds AI-powered ECG analysis tools for cardiovascular care, used by clinicians and health systems for instant ECG interpretation and…
NanoPhoriaNanoPhoria develops inhalable Nano-in-Micro delivery formulations to enable tissue-directed delivery of therapeutic peptides and RNAs for…
AltraTechAltraTech builds a portable, automated multimodal molecular diagnostic platform that detects and quantifies DNA, RNA, antibodies and…
Fred Hutchinson Cancer CenterFred Hutchinson Cancer Center conducts biomedical research and provides cancer patient care, offering prevention, early-detection, genetic…
NKINKI conducts cancer research and provides patient care, developing fundamental, translational and clinical research, technologies and…
BioretecBioretec designs and manufactures bioabsorbable orthopedic implants, including RemeOs™ absorbable metal and Activa™ PLGA implants for…
Cyted HealthCyted Health builds a diagnostic platform combining minimally invasive cell collection with molecular analysis to detect Barrett’s…
Tactile Medical ($TCMD)Tactile Medical develops and supplies medical devices and patient support for managing lymphatic and related fluid disorders, used by…
FineHeartFineHeart develops cardiovascular medical devices in France, including FlowMaker®, a fully implantable mechanical circulatory support…
Owlstone MedicalOwlstone Medical builds Breath Biopsy products and breath analyzers for non-invasive biomarker discovery, diagnostic test development and…
Bluedrop MedicalBluedrop Medical builds an at-home smart scale that scans feet in under 30 seconds; for people with diabetes and their providers to monitor…